Molecular Targeted Drugs and Biomarkers in NSCLC, the Evolving Role of Individualized Therapy

Lung cancer first line treatment has been directed from the non-specific cytotoxic doublet chemotherapy to the molecular targeted. The major limitation of the targeted therapies still remains the small number of patients positive to gene mutations. Furthermore, the differentiation between second lin...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Domvri, Kalliopi, Zarogoulidis, Paul, Darwiche, Kaid, Browning, Robert F., Li, Qiang, Turner, J. Francis, Kioumis, Ioannis, Spyratos, Dionysios, Porpodis, Konstantinos, Papaiwannou, Antonis, Tsiouda, Theodora, Freitag, Lutz, Zarogoulidis, Konstantinos
Format: Artigo
Sprache:Inglês
Veröffentlicht: Ivyspring International Publisher 2013
Schlagworte:
Review
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3842443/
https://ncbi.nlm.nih.gov/pubmed/24312144
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.7734
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge